Donald Joseph Brooks

Mr. Donald Joseph Brooks

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2024 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
FMFranck Fortune Mboussou
Franck Fortune Mboussou
PNPatrick Nkamedjie
Patrick Nkamedjie
DODaniel Oyaole
Daniel Oyaole
BFBridget Farham
Bridget Farham
AAAjiri Atagbaza
Ajiri Atagbaza
BIBénido Impouma
Bénido Impouma
Most countries in Africa deployed digital solutions to monitor progress in rolling out COVID-19 vaccines. A rapid assessment of existing data systems for COVID-19 vaccines in the African region was conducted between May and July 2022, in 23 countries. Data were collected through interviews with key informants, identified among senior staff within Ministries of Health, using a semi-structured electronic questionnaire. At vaccination sites, individual data were collected in paper-based registers in five countries (21.7%), in an electronic registry in two countries (8.7%), and in the remaining 16 countries (69.6%) using a combination of paper-based and electronic registries. Of the 18 countries using client-based digital registries, 11 (61%) deployed the District Health Information System 2 Tracker, and seven (39%), a locally developed platform. The mean percentage of individual data transcribed in the electronic registries was 61% ± 36% standard deviation. Unreliable Internet coverage (100% of countries), non-payment of data clerks’ incentives (89%), and lack of electronic devices (89%) were the main reasons for the suboptimal functioning of digital systems quoted by key informants. It is critical for investments made and experience acquired in deploying electronic platforms for COVID-19 vaccines to be leveraged to strengthen routine immunization data management.

11 April 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
AVAlba Vilajeliu
Alba Vilajeliu
VVVictor Vega
Victor Vega
RGRandie Gibson
Randie Gibson
FNFrancisco Nogareda
Francisco Nogareda
XWXIAOJUN WANG
XIAOJUN WANG
ALAnn Lindstrand
Ann Lindstrand
Background/Objective: Historically, immunization programs have focused on infants, children, and women of reproductive age. COVID-19 vaccination prompted countries to vaccinate adults. The objective of this manuscript is to provide a global overview of adult immunization policies post COVID-19 pandemic. Methods: We summarized WHO Strategic Advisory Group of Experts on Immunization (SAGE) recommendations by adult group and analyzed the data reported in 2024 (2023) by WHO Member States (MS) via the WHO/UNICEF electronic Joint Reporting Form on Immunization (eJRF) on national immunization schedules, and from other sources by WHO region and income group. Results: WHO policy recommendations exist for most of the licensed vaccines targeting adults; however, the inclusion in national immunization schedules is higher in high-income (HICs) and middle-income (MICs) countries. For pregnant women, 90% of MS reported vaccination against COVID-19 (65% in low-income countries [LICs]), 63% against tetanus-containing vaccines (73% in LICs), 57% against influenza (4% in LICs), and 21% against pertussis-containing vaccines (all MICs and HICs). For health workers, 91% against COVID-19 (92% in LICs), 59% against influenza (4% in LICs), and 25% against hepatitis B (10% in LICs). For adults with chronic diseases, COVID-19 vaccination data were not available, 58% against influenza, and 23% against pneumococcal disease. For older adults, more than 90% of MS across all income groups reported COVID-19 vaccination, 59% against influenza (8% of LICs versus 89% of HICs), 17% against pneumococcal, and 7% against herpes zoster (HZ). Conclusion: The disparities in adult immunization policies across income groups highlight the need to improve access and strengthen vaccination efforts. A life course approach is essential to maximize the full potential of immunization across all ages.

25 October 2024 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
DBDonald Joseph Brooks
Donald Joseph Brooks
CKCarolyn Inae Kim
Carolyn Inae Kim
FMFranck Fortune Mboussou
Franck Fortune Mboussou
M. Carolina DanovaroM. Carolina Danovaro
M. Carolina Danovaro
Background: Strong information systems are essential for safe and effective immunization programs. The COVID-19 vaccine rollout presented all immunization information systems (IIS) with challenging demands—requiring in-depth vaccine implementation data at all health system levels in real time. The system development approaches taken by countries were heterogeneous, with some countries opting to adapt existing systems and others implementing new ones. Objective: Using data reported by Member States to the World Health Organization (WHO), we aim to develop a global understanding of (1) the types of IIS used to monitor COVID-19 vaccination implemented in 2021 and (2) the approaches taken by countries to develop these systems. Methods: We conducted a descriptive analysis of data reported through a supplemental questionnaire of the WHO/United Nations Children's Emergency Fund (UNICEF) Joint Reporting Form on Immunization, collecting data for 2021 on (1) the use of and developmental approaches taken for 7 IIS functions (appointments, aggregate reporting, individual-level reporting, reminders, home-based records, safety surveillance, and stock management), and (2) modifications needed for digital health frameworks to permit COVID-19 vaccination monitoring. Results: In total, 188 of 194 WHO Member States responded to the supplemental questionnaire, with 155 reporting on the IIS-related questions. Among those reporting, for each of the 7 IIS functions explored, greater than 85% of responding countries reported that the system was in place for COVID-19 vaccines. Among responding countries, “aggregate reporting system” was the system most frequently reported as being in place (n=116, 98.3%), while “reminder system” was the least (n=77, 89%). Among the countries reporting using a system, whether an existing system was adapted for COVID-19 vaccines or a new one was developed varied by system. Additionally, two-thirds (n=127, 67.6%) of countries reported establishing at least one new system, ranging from 72% (n=42) in high-income countries (HICs) to 62% (n=16) in low-income countries. Concurrently, 55.3% (n=104) of countries reported adapting at least one system already in place for COVID-19 vaccines, with 62% (n=36) of HICs reporting this compared to about 53% for other income groups. Of those reporting developing new systems, for each of the systems explored, more than 85% of countries reported that they intended to keep new systems specific to COVID-19 vaccines. Further, 147 of the 188 (78.2%) Member States responding to the supplemental questionnaire responded to the digital health frameworks question. Lastly, 31% (n=46) of responding countries reported needing to adapt them for COVID-19 vaccination systems. HICs had a higher percentage. Conclusions: Nearly all countries have adapted existing or developed new IIS to monitor COVID-19 vaccination. The approaches varied, notably by income group. Reflection is needed on how to sustain the investments made in IIS during the pandemic. Continued support for IIS is critical, given their essential role in program monitoring and performance.

5 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
AVAlba Vilajeliu
Alba Vilajeliu
VVVictor Vega
Victor Vega
RGRandie Gibson
Randie Gibson
FNFrancisco Nogareda
Francisco Nogareda
XWXIAOJUN WANG
XIAOJUN WANG
ALAnn Lindstrand
Ann Lindstrand
Background: Historically, immunization programmes have focused on infants, children, and women of reproductive age. COVID-19 vaccination prompted countries to vaccinate adults. This manuscript provides a global overview of adult immunization post COVID-19 pandemic. Methods: We summarized WHO Strategic Advisory Group of Experts on Immunization (SAGE) recommendations by adult group and analyzed the data reported in 2024 (2023) by WHO Member States (MS) via the WHO/UNICEF electronic Joint Reporting Form on Immunization (eJRF) on national immunization schedules, and from other sources by WHO region and income group. Results: WHO policy recommendations exist for most of the licensed vaccines targeting adults; however, the inclusion in national immunization schedules is higher in high-income (HICs) and middle-income (MICs) countries. For pregnant women, 90% of MS reported vaccination against COVID-19 (65% in low-income countries [LICs]), 63% against tetanus-containing vaccines (73% in LICs), 57% against influenza (4% in LICs), and 21% against pertussis-containing vaccines (all MICs and HICs). For health workers, 91% against COVID-19 (92% in LICs), 59% against influenza (4% in LICs), and 25% against hepatitis B (10% in LICs). For adults with chronic diseases, COVID-19 vaccination data were not available, 58% against influenza, and 23% against pneumococcal disease. For older adults, more than 90% of MS across all income groups reported COVID-19 vaccination, 59% against influenza (8% of LICs versus 89% of HICs), 17% against pneumococcal, and 7% against herpes zoster. Conclusion: The disparities in adult immunization policies across income groups highlight the need to improve access and strengthen vaccination efforts. A life course approach is essential to maximize the full potential of immunization across all ages.

29 May 2024 in JMIR Preprints
Verified
Preprint
Open access
DBDonald Joseph Brooks
Donald Joseph Brooks
CKCarolyn Inae Kim
Carolyn Inae Kim
FMFranck Fortune Mboussou
Franck Fortune Mboussou
M. Carolina DanovaroM. Carolina Danovaro
M. Carolina Danovaro
BACKGROUND The COVID-19 vaccine rollout presented all immunization information systems (IIS) with challenging demands – requiring in-depth vaccine implementation data at all health system levels in real-time. The system development approaches taken by countries were heterogeneous, with some countries opting to adapt existing systems and others implementing new ones. OBJECTIVE Using data reported by Member States to the World Health Organization (WHO), develop a global understanding of a) the types of IIS to monitor COVID-19 vaccination implemented in 2021 and b) the approaches taken by countries to develop these systems. METHODS A descriptive analysis of data reported through a supplemental questionnaire of the WHO/UNICEF Joint Reporting Form for Immunization, collecting data for 2021 on a) the use of and developmental approaches taken for seven IIS functions, and b) on modifications needed to digital health frameworks to permit COVID-19 vaccination monitoring. RESULTS 188 of 194 WHO Member States reported data. For each of the seven IIS functions explored, greater than 85% of responding countries reported that the system was in place for COVID-19 vaccines. In total, two in three (68%) countries reported establishing at least one new system, ranging from 72% in high-income countries (HIC) to 61% in low-income countries (LICs). Concurrently, many countries adapted existing systems to include COVID-19 vaccines, notably those for stock management and safety surveillance. Overall, 55% of countries reported adapting at least one system already in place to COVID-19 vaccines, with 62% of HICs reporting this compared to ~53% for other income groups. On digital health frameworks, 31% of responding countries reported needing to adapt them in relation to COVID-19 vaccination systems, mostly HICs. CONCLUSIONS Nearly all countries have adapted existing and / or developed new IIS to monitor COVID-19 vaccination. The approaches varied, notably by income group. Reflection is needed on how to sustain investments made in IIS during the pandemic. Continued support for IIS is critical, given their essential role in program monitoring and performance.

27 May 2026 in Nature Health
Verified
Journal Article
Open access
PDF file
DBDonald Joseph Brooks
Donald Joseph Brooks
AAAyşe Açma
Ayşe Açma
RGRebecca Grant
Rebecca Grant
LSLorenzo Subissi
Lorenzo Subissi
JGJeffrey Gilbert
Jeffrey Gilbert
MKMaria Van Kerkhove
Maria Van Kerkhove